News

Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization in the United Kingdom (UK) for VIMKUNYA® ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (1 May 2025) approved a vaccine (Vimkunya) used to ...
Recommendations for the use of chikungunya vaccine were recently discussed at a meeting of the Advisory Committee on Immunization Practices.
The UK Health Security Agency said the number of serious illnesses infecting UK holidmakers has soared in the last 12 months ...
Shares in Valneva plunged after the company said France's health authorities suspended the use of its chikungunya vaccine, Ixchiq, for people aged 65 and older, raising concerns about the vaccine's ...
According to Benzinga, the approval is a milestone not only for Brazil but also for regions struggling with chikungunya ...
You have this convergence of crises,” says Dr. Angelle Desiree LaBeaud. Here’s what that means and how she and others are ...
Dianne Elliot took a three-week, seven-country trip that included stops in the United Kingdom, Egypt, India, Cambodia, Jordan, Indonesia and Oman. Some of those countries require ...
2025 AFP - LUIS ROBAYO Chikungunya is caused by a virus spread by Aedes mosquitoes. The World Health Organisation (WHO) says ...
A panel of federal health experts recommended expanded vaccine options for several diseases, including RSV, meningitis, and chikungunya.
The ACIP voted to recommend a precaution related to the use of Ixchiq in patients aged 65 years and older. Recommendations for the use of chikungunya vaccine were recently discussed at a meeting ...